CG Oncology (CGON) Director Leonard E. Post Exercises Options, Sells 1,000 Shares

What Happened

• Leonard E. Post, a director of CG Oncology (CGON), exercised options to acquire 1,000 shares at $0.60 per share (cost $600) and sold 1,000 shares the same day at $71.17 per share for proceeds of $71,170. The filing also reports a 1,000-share derivative disposition recorded at $0.00; the filing does not detail the mechanics of that entry.
• Overall this was an exercise-and-sell transaction (exercise indicated by code M, sale by code S), not a straightforward market purchase.

Key Details

• Transaction date: July 15, 2026; Form 4 filed July 17, 2026. Filing covers the July 15 transactions and was submitted promptly.
• Prices and amounts: exercised 1,000 shares at $0.60 (cost $600); sold 1,000 shares at $71.17 (proceeds $71,170); one derivative disposition of 1,000 shares reported at $0.00.
• Footnotes: Sale was effected under a Rule 10b5-1 trading plan adopted March 5, 2026 (F1). Options/shares were fully vested (F2).
• Shares owned after transaction: not disclosed in the provided filing details.

Context

• This appears to be a typical exercise-and-sell (cashless) sequence where the insider exercises options and sells shares the same day; the use of a Rule 10b5-1 plan indicates the sale was pre-planned rather than an ad-hoc trade.
• The additional 1,000-share derivative entry recorded at $0.00 is noted in the filing but not explained; the report does not imply further intent.
• For retail investors: exercises followed immediately by sales are common for insiders realizing option value; purchases are generally considered a stronger bullish signal than routine option exercises followed by sales.